Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun:39:31-36.
doi: 10.1016/j.parkreldis.2017.01.015. Epub 2017 Feb 1.

The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease

Affiliations

The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease

Sonja Rutten et al. Parkinsonism Relat Disord. 2017 Jun.

Abstract

Introduction: While anxiety, depression and insomnia frequently (co-)occur in Parkinson's disease (PD) patients, little is known about their temporal relationship. In this study, we tested two hypotheses: i) insomnia predicts an increase in symptoms of depression or anxiety and ii) anxiety or depression at baseline predicts insomnia in PD patients six months later.

Methods: We used longitudinal data from a prospective cohort study of early-stage, medication-naïve PD patients. Primary outcome measures were: anxiety symptoms, measured with the State-Trait Anxiety Inventory (STAI); depressive symptoms, measured with the 15-item Geriatric Depression Scale (GDS-15); and insomnia, defined as a score ≥ 2 on item 1.7 of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale. We performed linear and logistic regression analyses, correcting for baseline value of the respective outcome variable.

Results: Baseline insomnia was not associated with GDS-15 or STAI total score at follow-up. In a post hoc analysis, we found that insomnia predicted a higher STAI State score (B(SE) = 2.50 (1.07), p < 0.05), while the association with the STAI Trait score was not significant. Baseline STAI scores (B(SE) = 0.02 (0.01), p = 0.001) and GDS-15 score (B(SE) = 0.15 (0.05), p < 0.001) were significantly associated with insomnia at follow-up.

Conclusion: Symptoms of anxiety and depression may constitute a risk factor for insomnia in PD. The relationship between insomnia and anxiety is bidirectional, which suggests that both anxiety and sleep disorders can start a negative spiral in PD patients, where one enhances the other. Independent clinical attention for these symptoms in PD patients is therefore warranted.

Keywords: Anxiety; Depression; Insomnia; Longitudinal; Parkinson's disease; Risk factor.

PubMed Disclaimer

Conflict of interest statement

Competing interests

None

Figures

Figure 1
Figure 1
Flow chart

References

    1. Karlsen KHTE, Årsland D, Larsen JP. Health related quality of life in Parkinson’s disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 2000;69:584–89. - PMC - PubMed
    1. Karlsen KHLJ, Tandberg E, et al. The influence of clinical and demographic variables on quality of life in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;66:431–35. - PMC - PubMed
    1. Hughes TARH, Mindham RH, et al. Mortality in Parkinson’s disease and its association with dementia and depression. Acta neurologica Scandinavica. 2004;110(2):118–23. - PubMed
    1. Starkstein SEMH, Leiguarda R, et al. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson’s disease. Journal of neurology, neurosurgery, and psychiatry. 1992;55(5):377–82. - PMC - PubMed
    1. Siemers ERSA, Quaid K, et al. Anxiety and motor performance in Parkinson’s disease. Mov Disord. 1993;8(4):501–06. - PubMed

Publication types